Trial Profile
Investigator-initiated multi-center, double-blinded, randomized clinical trial of WILATE in patients with congenital hemophilia A.
Status:
Planning
Phase of Trial:
Phase IV
Latest Information Update: 29 Nov 2016
Price :
$35
*
At a glance
- Drugs Factor VIII/von Willebrand factor (Primary)
- Indications Haemophilia A
- Focus Pharmacodynamics
- Acronyms INITIATE
- 29 Nov 2016 New trial record